Equity Investees (Tables)

9 Months Ended

Sep. 30, 2013

Equity Method Investments and Joint Ventures [Abstract]

Consolidated Financial Statements Related To Equity Investees

The following table presents information included in our Unaudited Condensed Consolidated Financial Statements related to our equity investees.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Genesis’ share of operating earnings	$	9,641		$	5,978		$	24,512		$	15,611
Amortization of excess purchase price	(2,582		)	(2,546		)	(7,894		)	(7,640		)
Net equity in earnings	$	7,059		$	3,432		$	16,618		$	7,971
Distributions received	$	11,610		$	9,045		$	32,624		$	27,069

Schedule Of Balance Sheet Information For Equity Investees

The following tables present the combined unaudited balance sheet and income statement information (on a 100% basis) of our equity investees:

	September 30, 2013		December 31, 2012
BALANCE SHEET DATA:
Assets
Current assets	$	83,886	$	74,906
Fixed assets, net	1,021,106		832,525
Other assets	7,727		10,202
Total assets	$	1,112,719	$	917,633
Liabilities and equity
Current liabilities	$	78,979	$	112,321
Other liabilities	182,210		134,731
Equity	851,530		670,581
Total liabilities and equity	$	1,112,719	$	917,633

Schedule Of Operations For Equity Investees

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
INCOME STATEMENT DATA:
Revenues	$	49,239	$	39,799	$	135,507	$	113,769
Operating income	$	28,419	$	19,810	$	75,946	$	53,597
Net income	$	27,725	$	19,196	$	73,928	$	51,553